XVI International AIDS Conference: Part 2

AIDS Read. 2006 Nov;16(11):581-4, 591-2.

Authors

Brian A Boyle¹, Calvin J Cohen, Graeme J Moyle, Richard Elion, Paul E Sax, Ian Frank

Affiliation

¹ Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, USA.

PMID: 17152645

No abstract available

Publication types

Congress

MeSH terms

Acquired Immunodeficiency Syndrome / drug therapy*
CCR5 Receptor Antagonists
Clinical Trials as Topic
Darunavir
HIV Infections / drug therapy*
HIV Protease Inhibitors / therapeutic use*
HIV*
Humans
Lopinavir
Organic Chemicals / therapeutic use
Pyrimidinones / therapeutic use
Pyrrolidinones
Raltegravir Potassium
Receptors, CCR5 / therapeutic use
Ritonavir / therapeutic use
Salvage Therapy
Sulfonamides / therapeutic use

Substances

CCR5 Receptor Antagonists
HIV Protease Inhibitors
Organic Chemicals
Pyrimidinones
Pyrrolidinones
Receptors, CCR5
Sulfonamides
Lopinavir
Raltegravir Potassium
Ritonavir
Darunavir